ARCHIVES

J&J To Eliminate Its Ortho Biotech Unit As FDA Considers Further Limits On ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 17 | May 2, 2008

Download PDF Visit The Full Archive

Related Articles

As Leadership Changes Continue, Fontaine, Leach Get New Posts

January 17, 2014

Senate Investigates Opioid Manufacturers, Requests Study of Impact of DEA Policies

May 11, 2012

Clinton to Propose Increase for NIH & NCI Significantly Higher Than In Previous Years

January 9, 1998

Certification Means More Money for Nurses, ONS Finds

June 29, 1990

Mack, to Retire, Calls Budget Proposal an “Act of Retreat”

March 19, 1999

DRCCA Board Approves Concepts Of Four New Antismoking Projects

May 20, 1983